Zacks Investment Research | Feb 19, 2020 03:35AM ET
Shares of Henry Schein (NASDAQ:HSIC), Inc. HSIC reached a new 52-week high of $73.25 on Feb 18, before closing the session marginally lower at $72.99. The stock has rallied 7.8% since its third-quarter 2019 earnings announcement on Nov 5.
The company is witnessing an upward trend in its stock price, prompted by its impressive product lineup and partnerships. Its strong international performance in the last reported quarter also contributed to the top line. Further, solid performance by each of its key operating businesses in the third quarter 2019, backed by strong share gains in the North American market, boosted the market sentiment about its fourth-quarter results (to be released on Feb 20).
Let us delve deeper.
Recent Partnerships
Investors are upbeat about Henry Schein’s distribution agreement with Ivoclar Vivadent AG in December 2019 for the distribution of the new PrograMill One Milling System. Notably, this will add value to Henry Schein’s portfolio of digital dentistry solutions.
In January, Henry Schein also inked a partnership deal with United Parcel Service (NYSE:UPS) to explore and test a variety of drone delivery use cases. The use cases would examine unmanned aerial vehicles within business-to-business operating models. Through the collaboration, Henry Schein will focus on exploring the possibility of transporting essential healthcare products by UPS to its customers.
Other Growth Drivers
Product Pipeline: Investors are optimistic about the company’s product pipeline, which includes new solutions, and product offerings like Amann Girrbach PL900S mill, Dentsply Sirona CEREC Primemill and Planmeca Emerald S Scanner. The products will be showcased in the upcoming Dental Meeting (to be held between Feb 20 and Feb 22, 2020).
Apart from these, the company’s product pipeline includes 3Shape TRIOS Move, 3Shape TRIOS 3 Basic, the A-dec 500 Chair, Convergent Dental Solea Dental Laser and Dentsply Sirona CEREC Primescan. All the above-mentioned products were demonstrated by the company in a meeting in December 2019. The opportunity to enhance clinician workflows through these products buoys optimism.
Further, through its joint venture with Internet Brands — Henry Schein One — the company announced the availability of the Dentrix Smart Image connector for DEXIS last November. The integration will enable oral health professionals to automate practice management with DEXIS software tightly woven into Dentrix workflows.
Q3 Performance: Following Henry Schein’s impressive third-quarter 2019 earnings show, investors are upbeat about its solid organic growth in the Medical sales business on the North American Rescue acquisition. Over the past few quarters, the company has been registering strong top-line results on Henry Schein One’s strong execution of innovation and product launch strategy. A promising 2019 guidance is also indicative that the solid momentum will continue.
Dental Business Trends: Henry Schein’s strategy to expand digital dentistry globally boosts market sentiment. The company is currently focusing on promoting digital workflows for general dentistry and dental specialties. It is also working toward offering a diversified portfolio and value-added services along with strengthening end market.
Downsides
Impact of Group Purchasing Organizations: Headwinds like measures to curb capital expenditure, volume headwinds, pricing pressure and procedure deferrals led to some large integrated health care providers and group purchasing organizations (GPO) to gain extensive purchasing power. The GPOs act as agents that negotiate vendor contracts on behalf of their members, thus raising the pricing pressure in the industry as a whole.
Competitive Landscape: Henry Schein currently operates in an industry, which is highly competitive, and consists of national, regional and local distributors as well as bigshots like McKesson Corp (NYSE:MCK). Companies like Patterson Dental business of Patterson Companies Inc (NASDAQ:PDCO). and Benco Dental Supply pose stiff competition to Henry Schein in the North American dental products market.
Zacks Rank & Key Picks
Currently, the company carries a Zacks Rank #3 (Hold).
Some better-ranked stocks from the broader medical space are Phibro Animal Health Corp. Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.